Ignite Creation Date:
2024-05-05 @ 11:20 AM
Last Modification Date:
2024-10-26 @ 9:04 AM
Study NCT ID:
NCT00003794
Status:
TERMINATED
Last Update Posted:
2013-06-10
First Post:
1999-11-01
Brief Title:
Quality-of-Life Study of Patients With Previously Treated Ovarian Cancer
Sponsor:
Gynecologic Oncology Group
Organization:
GOG Foundation
Study Overview
Official Title:
Quality of Life in Ovarian Germ Cell Cancer Survivors
Status:
TERMINATED
Status Verified Date:
2005-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
RATIONALE Quality-of-life assessment of patients undergoing cancer treatment may help determine the intermediate- and long-term effects of treatment in patients with cancer
PURPOSE This clinical trial studies the quality of life in patients with previously treated ovarian cancer
PURPOSE This clinical trial studies the quality of life in patients with previously treated ovarian cancer
Detailed Description:
OBJECTIVES I Compare quality of life in terms of health status sexual functioning psychologicalemotional well being and social functioning in ovarian germ cell cancer survivors vs a matched healthy control group II Predict quality of life in these patients through the additive effects of cancer diagnosis and treatment sociodemographic characteristics other stressors and social network variables
OUTLINE Patients identify up to 3 healthy acquaintance controls within 3 years of the same age Patients and controls complete a written questionnaire which takes about 30 minutes and a telephone interview which takes about 1 hour to assess quality of life
PROJECTED ACCRUAL A total of 190 patients and 190 healthy controls will be accrued for this study within 2 years
OUTLINE Patients identify up to 3 healthy acquaintance controls within 3 years of the same age Patients and controls complete a written questionnaire which takes about 30 minutes and a telephone interview which takes about 1 hour to assess quality of life
PROJECTED ACCRUAL A total of 190 patients and 190 healthy controls will be accrued for this study within 2 years
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| GOG-9901 | None | None | None |